Conditions: Epilepsy, Partial
Keywords: Epilepsy Pediatric Partial onset epilepsy Levetiracetam Keppra
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 223
Healthy volunteers: no

Brief summary:
Open-label study to allow pediatric patients who have participated in prior Levetiracetam (Keppra®) studies to continue their treatment with adequate monitoring and standardized follow-up care until Levetiracetam (Keppra®) is approved for use in children or until the completion of the development program for pediatrics.

Detailed description:

Arms:
arm 1: Subjects had previously participated in study N159 in which they had received Placebo (PBO). arm 2: Subjects had previously participated in study N159 in which they had received Levetiracetam (LEV). arm 3: Subjects had previously participated in study N01010 or study N151 in which they had received Levetiracetam (LEV). arm 4: Subjects had previously participated in study N01052 in which they had received Levetiracetam (LEV).

Interventions: intervention 1: Levetiracetam
Intervention descriptions: intervention 1: * Pharmaceutical form: Oral tablets and oral solution
* Route of administration: Oral use

Protocol document: